Hypoxia-inducible factors mediate coordinated RhoA-ROCK1 expression and signaling in breast cancer cells
about
Sirtuins and Cancer: Role in the Epithelial-Mesenchymal TransitionNovel Insights into the Roles of Rho Kinase in CancerForms, forces, and stem cell fateStatistical analysis of cell migration in 3D using the anisotropic persistent random walk model.Cellular adhesome screen identifies critical modulators of focal adhesion dynamics, cellular traction forces and cell migration behaviour.Glycolysis is the primary bioenergetic pathway for cell motility and cytoskeletal remodeling in human prostate and breast cancer cells.Effect of QSKL on MAPK and RhoA Pathways in a Rat Model of Heart Failure.Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment.Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis.Estrogen-related receptor α decreases RHOA stability to induce orientated cell migration.Hypoxia and the extracellular matrix: drivers of tumour metastasisHypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype.Advancements in the development of HIF-1α-activated protein switches for use in enzyme prodrug therapy.Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinomaHIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells.Expression and prognostic significance of MYL9 in esophageal squamous cell carcinoma.The hypoxic tumor microenvironment: A driving force for breast cancer progression.CKD Stimulates Muscle Protein Loss Via Rho-associated Protein Kinase 1 Activation.Induction of WNT11 by hypoxia and hypoxia-inducible factor-1α regulates cell proliferation, migration and invasion.Hypoxia promotes Rab5 activation, leading to tumor cell migration, invasion and metastasis.Inhibitors of Rho kinase (ROCK) signaling revert the malignant phenotype of breast cancer cells in 3D contextHypoxia promotes tumor cell motility via RhoA and ROCK1 signaling pathways.Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.Genetic variants in RhoA and ROCK1 genes are associated with the development, progression and prognosis of prostate cancerRole of miR-155 in drug resistance of breast cancer.Hypoxia regulates RhoA and Wnt/β-catenin signaling in a context-dependent way to control re-differentiation of chondrocytes.MicroRNA-340 inhibits invasion and metastasis by downregulating ROCK1 in breast cancer cells.Targeting the RhoGTPase/ROCK pathway for the treatment of VHL/HIF pathway-driven cancers.Cell type-dependent HIF1 α-mediated effects of hypoxia on proliferation, migration and metastatic potential of human tumor cellsBi-content micro-collagen chip provides contractility-based biomechanical readout for phenotypic drug screening with expanded and profiled targets.Hypoxia and the modulation of the actin cytoskeleton - emerging interrelations.PLC-β2 is modulated by low oxygen availability in breast tumor cells and plays a phenotype dependent role in their hypoxia-related malignant potential.Hypoxia Selectively Enhances Integrin α5β1 Receptor Expression in Breast Cancer to Promote MetastasisRetinoblastoma protein (Rb) links hypoxia to altered mechanical properties in cancer cells as measured by an optical tweezer.Cell-Extracellular Matrix Mechanobiology: Forceful Tools and Emerging Needs for Basic and Translational Research.Nck deficiency is associated with delayed breast carcinoma progression and reduced metastasis.The CCR2 3'UTR functions as a competing endogenous RNA to inhibit breast cancer metastasis.Directional Migration of MDA-MB-231 Cells Under O2/pH Gradients.Preventative effects of a HIF inhibitor, 17-DMAG, on partial bladder outlet obstruction-induced bladder dysfunction.Diallyl trisulfides, a natural histone deacetylase inhibitor, attenuate HIF-1α synthesis, and decreases breast cancer metastasis.
P2860
Q26744502-AA60E6BF-1065-466E-9C80-BD08347B25CEQ26771368-46309877-5498-4255-8C87-3E158D3D1C09Q26995659-F52962C5-0576-4723-87F6-867CABD21D09Q27310361-988DA144-4558-49BC-8C5E-A7E9EFCF5145Q27316544-B5E10631-1AA0-4E46-AFC2-ACFA3F42D7CFQ30634365-256EF07A-69DB-4A75-A4B5-C6EA714DD241Q33623953-8E956834-BE8E-4514-B36F-4F351E7185CBQ33665254-AAD38229-C77F-40DA-B842-D0929F088FB8Q34025482-0D46F686-995F-472D-9560-947E9C843813Q34408834-6B992E20-0397-410F-BCBD-4E39FB0626D4Q34820282-38ECF5F9-EBE1-4594-A210-871D21F7CD46Q35149689-70383C89-17AA-4989-BC35-98480EB16C2AQ35451950-069D0ADD-129D-4B52-90D0-4FC12733F64FQ36191526-A9965C3C-5E81-4C0C-8E98-9BB1D2917BA1Q36300305-F29AD2F1-86E8-4D92-A094-79BC4E4DE0C8Q36340056-D3E551FB-8756-43E8-9FA9-B997E90FD07FQ36368931-8E9F7BDA-7438-4074-8024-ABA6D1F368E5Q36514936-F3DA4FF4-1F93-42B8-B74B-083E249CE3FFQ36565126-FA5A4C8C-6A2E-4D5B-B5F0-0CA9A1465EEFQ37301875-7F9728E2-BADD-4A71-8079-665A2181CD68Q37362471-A21DBBF7-742E-4342-B8D2-3666D22BB91BQ37519522-9E7CE07E-EB69-4915-B734-973DA6229ABBQ37662078-444478A3-46C9-4EBB-997D-618BD0045255Q37745990-46058719-D3AD-4006-A5BD-4DEB811D8963Q38368383-D365C919-C6B2-4CCD-9CE4-7A3A79516D44Q38613306-ECC2D1B7-8C8D-4A2A-83BF-6505029661FBQ38637994-66DF08C6-A1A7-4D74-BB54-A73E1EB3CBFBQ38668940-F9B447BA-F23B-4CDB-960E-F1ADDB6F439DQ38754112-86C2D5CA-2082-4828-86ED-2D1B1AF99E3DQ38848565-46134CCB-A072-4368-95EB-A8F3B14F9DDBQ38989120-B75BC89B-6389-43D0-953D-788BCDEF6063Q40088702-A524F1E9-79E4-41F9-9D6E-E5DC236564F6Q41015404-5A8F44E1-FC66-4E7F-B6D4-D543E01266EEQ41354217-60B63E39-9F47-4E60-8F3F-E86EEE863578Q47310923-5DB0C44A-87D0-4960-BBA1-9823AB227147Q47625162-FEEBD9C6-DC6C-42BE-B45C-C253A069DAF8Q47938283-A4C13183-7684-41FE-98CB-3EBF5E508740Q47950661-3CAF3B16-0EDE-4D13-82B9-34347D876922Q48303833-6AE3DAD1-9262-4F37-AF37-C755213BBB71Q48336312-BEA2C22A-078A-4AB7-B6C3-E3AE127888AE
P2860
Hypoxia-inducible factors mediate coordinated RhoA-ROCK1 expression and signaling in breast cancer cells
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Hypoxia-inducible factors medi ...... gnaling in breast cancer cells
@ast
Hypoxia-inducible factors medi ...... gnaling in breast cancer cells
@en
Hypoxia-inducible factors medi ...... gnaling in breast cancer cells
@nl
type
label
Hypoxia-inducible factors medi ...... gnaling in breast cancer cells
@ast
Hypoxia-inducible factors medi ...... gnaling in breast cancer cells
@en
Hypoxia-inducible factors medi ...... gnaling in breast cancer cells
@nl
prefLabel
Hypoxia-inducible factors medi ...... gnaling in breast cancer cells
@ast
Hypoxia-inducible factors medi ...... gnaling in breast cancer cells
@en
Hypoxia-inducible factors medi ...... gnaling in breast cancer cells
@nl
P2093
P2860
P3181
P356
P1476
Hypoxia-inducible factors medi ...... gnaling in breast cancer cells
@en
P2093
Daniele M Gilkes
Denis Wirtz
Lisha Xiang
Maimon E Hubbi
Pallavi Chaturvedi
Sun Joo Lee
P2860
P304
P3181
P356
10.1073/PNAS.1321510111
P407
P577
2014-01-21T00:00:00Z